P570: REAL-WORLD EFFICACY OUTCOMES OF VENETOCLAX PLUS AZACITIDINE VS INTENSIVE CHEMOTHERAPY FOR INDUCTION THERAPY IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA
A. M. Zeidan,
D. A. Pollyea,
U. Borate,
A. Vasconcelos,
R. Potluri,
D. Rotter,
Z. Kiendrebeogo,
L. Gaugler,
G. Bonifacio,
T. Prebet,
C. Chen
Affiliations
A. M. Zeidan
1 Yale University School of Medicine, New Haven, CT
D. A. Pollyea
2 University of Colorado School of Medicine, Aurora, CO
U. Borate
3 Oregon Health & Science University, Portland, OR
A. Vasconcelos
4 Bristol Myers Squibb, Princeton, NJ
R. Potluri
5 SmartAnalyst Inc., New York, NY, United States of America
D. Rotter
5 SmartAnalyst Inc., New York, NY, United States of America
Z. Kiendrebeogo
5 SmartAnalyst Inc., New York, NY, United States of America
